Endoscopic subureteral injection treatment with calcium hydroxylapatite in primary vesicoureteral reflux

被引：6

作者：

Eryildirim, Bilal ^{[1
]}

Tarhan, Fatih ^{[1
]}

Kuyumcuoglu, Ugur ^{[1
]}

Erbay, Erkan ^{[1
]}

Faydaci, Goekhan ^{[1
]}

机构：

[1] Dr Lutfi Kirdar Kartal Training & Res Hosp, Urol Clin, Istanbul, Turkey

来源：

INTERNATIONAL UROLOGY AND NEPHROLOGY | 2007年 / 39卷 / 02期

关键词：

calcium hydroxylapatite; endoscopic; injection; vesicoureteral reflux;

D O I：

10.1007/s11255-006-9011-y

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Introduction In this study, we aimed to evaluate efficiency of subureteral injection of calcium hydroxylapatite treatment for primary vesico-ureteral reflux (VUR). Materials and methods A total of 25 children (mean age 6.9 +/- 2.7 years) underwent subureteral injection of calcium hydroxylapatite for primary VUR. Reflux was present in 39 ureteral units that were unilateral in 11 cases and bilateral in 14 cases. According to "International Reflux Classification"; grade II in 12 (30.8%), grade III in 18 (46.2%) and grade IV in 9 (23.1%) ureteral units were found. Results The refluxes were resolved in 23 (59.0%) ureteral units after a single injection and 5 ureteral units (12.8%) after a second injection. Overall success rate of reflux treatment with calcium hydroxylapatite was 71.8% in all ureteral units. Conclusion Endoscopic subureteral injection of calcium hydroxylapatite in children with primary low-grade VUR appears to be an effective, safe and minimally invasive technique.

引用

页码：417 / 420

页数：4

共 19 条

[1]

ABRAMS P, 2002, EUR UROL SUPPL, V1, P618

[2] Outcome of endoscopic treatment for vesicoureteral reflux in children using polydimethylsiloxane [J].

Al-Hunayan, AA ;

Kehinde, EO ;

Elsalam, MA ;

Al-Mukhtar, RS .

JOURNAL OF UROLOGY, 2002, 168 (05) :2181-2183

[3]

Atala A, 2002, CAMPBELLS UROLOGY, P2053

[4]

BAILEY RR, 1993, DIS KIDNEY, P689

[5] Long-term results of the endoscopic correction of vesicoureteral reflux in children using autologous chondrocytes [J].

Caldamone, AA ;

Diamond, DA .

JOURNAL OF UROLOGY, 2001, 165 (06) :2224-2227

[6] Endoscopic treatment of primary grades IV and V vesicoureteral reflux in children with subureteral injection of polytetrafluoroethylene [J].

Chertin, B ;

De Caluwé, D ;

Puri, P .

JOURNAL OF UROLOGY, 2003, 169 (05) :1847-1849

[7] Endoscopic management of vesicoureteral reflux: Does it stand the test of time? [J].

Chertin, B ;

Puri, P .

EUROPEAN UROLOGY, 2002, 42 (06) :598-606

[8] Failure of subureteral bovine collagen injection for the endoscopic treatment of primary vesicoureteral reflux in long-term follow-up [J].

Haferkamp, A ;

Contractor, H ;

Möhring, K ;

Staehler, G ;

Dörsam, J .

UROLOGY, 2000, 55 (05) :759-763

[9] New advances in injectable therapies for the treatment of incontinence and vesicoureteral reflux [J].

Kershen, RT ;

Atala, A .

UROLOGIC CLINICS OF NORTH AMERICA, 1999, 26 (01) :81-+

[10] Endoscopic subureteral collagen injection: Are immunological concerns justified? [J].

Leonard, MP ;

Decter, A ;

Hills, K ;

Mix, LW .

JOURNAL OF UROLOGY, 1998, 160 (03) :1012-1016

← 1 2 →